Answers are grounded in this paper and cite their sources.
Background: Cold Ischemia-Reperfusion Injury (CIRI) is regarded as the major cause of early graft dysfunction after cardiac transplantations and is associated with rejection episodes. Consequently, it is one of the main therapeutic targets in order to improve survival after heart transplantation. The aim of this study was to evaluate hemodynamic effects of milrinone and its influence on the markers of myocardial damage when used in a piglet working heart model with a cold ischemia-reperfusion setting.
No takes yet. Share an insight, caveat, or question.
Mario Lescan Albertus Scheule (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: